<?xml version='1.0' encoding='utf-8'?>
<document id="20851283"><sentence text="Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder."><entity charOffset="25-36" id="DDI-PubMed.20851283.s1.e0" text="carbapenems" /><entity charOffset="58-75" id="DDI-PubMed.20851283.s1.e1" text="divalproex sodium" /><pair ddi="false" e1="DDI-PubMed.20851283.s1.e0" e2="DDI-PubMed.20851283.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20851283.s1.e0" e2="DDI-PubMed.20851283.s1.e1" /></sentence><sentence text="Clinicians prescribing divalproex sodium (DVX) are well aware of its potential to cause a drug-drug interaction"><entity charOffset="23-40" id="DDI-PubMed.20851283.s2.e0" text="divalproex sodium" /><entity charOffset="42-45" id="DDI-PubMed.20851283.s2.e1" text="DVX" /><pair ddi="false" e1="DDI-PubMed.20851283.s2.e0" e2="DDI-PubMed.20851283.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20851283.s2.e0" e2="DDI-PubMed.20851283.s2.e1" /></sentence><sentence text=" One specific interaction occurs between the carbapenem antibiotics and DVX resulting in decreased valproic acid (VPA) levels immediately following the initiation of this antibiotic class"><entity charOffset="45-55" id="DDI-PubMed.20851283.s3.e0" text="carbapenem" /><entity charOffset="99-112" id="DDI-PubMed.20851283.s3.e1" text="valproic acid" /><entity charOffset="114-117" id="DDI-PubMed.20851283.s3.e2" text="VPA" /><entity charOffset="72-74" id="DDI-PubMed.20851283.s3.e3" text="DVX" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e0" e2="DDI-PubMed.20851283.s3.e0" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e0" e2="DDI-PubMed.20851283.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e0" e2="DDI-PubMed.20851283.s3.e1" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e0" e2="DDI-PubMed.20851283.s3.e2" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e3" e2="DDI-PubMed.20851283.s3.e3" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e3" e2="DDI-PubMed.20851283.s3.e1" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e3" e2="DDI-PubMed.20851283.s3.e2" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e1" e2="DDI-PubMed.20851283.s3.e1" /><pair ddi="false" e1="DDI-PubMed.20851283.s3.e1" e2="DDI-PubMed.20851283.s3.e2" /></sentence><sentence text="" /><sentence text="We describe a case of a 46 year-old Caucasian male who had an undetectable VPA level following treatment with carbapenems"><entity charOffset="110-121" id="DDI-PubMed.20851283.s5.e0" text="carbapenems" /><entity charOffset="75-85" id="DDI-PubMed.20851283.s5.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.20851283.s5.e1" e2="DDI-PubMed.20851283.s5.e1" /><pair ddi="false" e1="DDI-PubMed.20851283.s5.e1" e2="DDI-PubMed.20851283.s5.e0" /></sentence><sentence text="" /><sentence text="On admission the patient's VPA level was 115 μg/ml; however, a routine VPA level on day 19 of his hospitalization returned a value of 16 μg/ml"><entity charOffset="27-29" id="DDI-PubMed.20851283.s7.e0" text="VPA" /><entity charOffset="71-73" id="DDI-PubMed.20851283.s7.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.20851283.s7.e0" e2="DDI-PubMed.20851283.s7.e0" /><pair ddi="false" e1="DDI-PubMed.20851283.s7.e0" e2="DDI-PubMed.20851283.s7.e1" /></sentence><sentence text=" At this point, he had received a total of 15 days of carbapenem antibiotics for treatment of lower leg cellulitis"><entity charOffset="54-64" id="DDI-PubMed.20851283.s8.e0" text="carbapenem" /></sentence><sentence text=" His DVX dose was increased to a maximum of 6g daily, twice his home dose, but it did not produce a therapeutic VPA concentration"><entity charOffset="5-14" id="DDI-PubMed.20851283.s9.e0" text="DVX" /><entity charOffset="112-121" id="DDI-PubMed.20851283.s9.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.20851283.s9.e0" e2="DDI-PubMed.20851283.s9.e0" /><pair ddi="false" e1="DDI-PubMed.20851283.s9.e0" e2="DDI-PubMed.20851283.s9.e1" /></sentence><sentence text=" The patient was lost to follow-up before an outpatient VPA level was drawn"><entity charOffset="56-58" id="DDI-PubMed.20851283.s10.e0" text="VPA" /></sentence><sentence text="" /><sentence text="Our case report is the first to document this drug-drug interaction in a patient diagnosed with schizoaffective disorder, bipolar type" /><sentence text="" /></document>